Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in TVTX / Travere Therapeutics, Inc.

On February 11, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 51,241 shares of Travere Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 101,600 of underlying shares valued at $3,018,536 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -51,241 -100.00 0 -100.00
2025-11-12 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 51,241 51,241 1 0.0006
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -13,242 -100.00 0 0.0000
2025-02-11 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 13,242 -27,219 -67.27 0 0.0001
2024-11-08 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 40,461 -40,528 -50.04 1 0.0003
2024-07-25 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 80,989 69,591 610.55 1 0.0004
2024-04-25 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 11,398 11,398 0 0.0001
2023-08-04 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -4,793 -100.00 0 0.0000
2023-04-27 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 4,793 4,793 0 0.0001
2023-02-02 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -4,256 -100.00 0 -100.00
2022-11-04 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 4,256 -3,548 -45.46 104 -44.97 0.0001
2022-08-03 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,804 7,044 926.84 189 894.74 0.0002
2022-05-02 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 760 -3,712 -83.01 19 -86.23 0.0000
2022-02-23 2021-12-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 4,472 -10,799 -70.72 138 -42.02 0.0001
2022-02-04 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 15,271 0 238 0.0001
2021-10-28 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 15,271 383 2.57 238 9.68 0.0002
2021-08-12 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 14,888 12,800 613.03 217 317.31 0.0002
2021-04-26 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 2,088 2,088 -85.98 52 -76.04 0.0001
2020-10-14 2020-09-30 13F RETROPHIN COM 761299106 0 -1,236 -100.00 0 -100.00
2020-07-13 2020-06-30 13F RETROPHIN COM 761299106 1,236 1,236 25 0.0000
2020-04-28 2020-03-31 13F RETROPHIN COM 761299106 0 -132 -100.00 0 -100.00
2020-02-05 2019-12-31 13F RETROPHIN COM 761299106 132 -4,411 -97.09 1 -98.08 0.0000
2019-10-15 2019-09-30 13F RETROPHIN COM 761299106 4,543 4,543 3,341.67 52 5,100.00 0.0001
2019-04-18 2019-03-31 13F RETROPHIN COM 761299106 0 -17,548 -100.00 0 -100.00
2019-01-16 2018-12-31 13F RETROPHIN COM 761299106 17,548 17,548 397 0.0012
2018-10-23 2018-09-30 13F RETROPHIN COM 761299106 0 -444 -100.00 0 -100.00
2018-07-30 2018-06-30 13F RETROPHIN COM 761299106 444 444 12 0.0000
2018-04-26 2018-03-31 13F RETROPHIN COM 761299106 0 -839 -100.00 0 -100.00
2018-01-10 2017-12-31 13F RETROPHIN COM 761299106 839 839 17 0.0007
2017-04-21 2017-03-31 13F RETROPHIN COM 761299106 0 -19,331 -100.00 0 -100.00
2017-01-11 2016-12-31 13F RETROPHIN COM 761299106 19,331 -1,200 -5.84 365 -20.48 0.0218
2016-10-07 2016-09-30 13F RETROPHIN COM 761299106 20,531 15,719 326.66 459 440.00 0.0311
2016-07-18 2016-06-30 13F RETROPHIN COM 761299106 4,812 4,034 518.51 85 750.00 0.0057
2016-04-14 2016-03-31 13F RETROPHIN COM 761299106 778 -2,471 -76.05 10 -83.87 0.0008
2016-01-20 2015-12-31 13F RETROPHIN COM 761299106 3,249 3,249 317.61 62 520.00 0.0049
2015-10-08 2015-09-30 13F RETROPHIN COM 761299106 0 -4,796 -100.00 0 -100.00
2015-07-08 2015-06-30 13F RETROPHIN COM 761299106 4,796 4,796 0.00 158 0.0132
2015-04-21 2015-03-31 13F RETROPHIN COM 761299106 0 -3,544 -100.00 0 -100.00
2015-03-04 2014-12-31 13F RETROPHIN COM 761299106 3,544 3,544 43 0.0052
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F TRAVERE THERAPEUTICS CALL Call 101,600 -50.00 3,019 -61.13 n/a n/a n/a
2026-02-11 2025-12-31 13F TRAVERE THERAPEUTICS CALL Call 203,200 -2.07 7,764 194,000.00 n/a n/a n/a
2025-11-12 2025-09-30 13F TRAVERE THERAPEUTICS CALL Call 207,500 85.43 5 300.00 n/a n/a n/a
2025-08-05 2025-06-30 13F TRAVERE THERAPEUTICS CALL Call 111,900 37.47 2 0.00 n/a n/a n/a
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS CALL Call 81,400 60.87 1 n/a n/a n/a
2025-02-11 2024-12-31 13F TRAVERE THERAPEUTICS CALL Call 50,600 30.41 1 n/a n/a n/a
2024-11-08 2024-09-30 13F TRAVERE THERAPEUTICS CALL Call 38,800 10.23 1 n/a n/a n/a
2024-07-25 2024-06-30 13F TRAVERE THERAPEUTICS CALL Call 35,200 84.29 0 n/a n/a n/a
2024-04-25 2024-03-31 13F TRAVERE THERAPEUTICS CALL Call 19,100 -59.87 0 n/a n/a n/a
2024-02-02 2023-12-31 13F TRAVERE THERAPEUTICS CALL Call 47,600 -31.71 0 n/a n/a n/a
2023-11-01 2023-09-30 13F TRAVERE THERAPEUTICS CALL Call 69,700 1,891.43 1 n/a n/a n/a
2023-08-04 2023-06-30 13F TRAVERE THERAPEUTICS CALL Call 3,500 -50.70 0 n/a n/a n/a
2023-04-27 2023-03-31 13F TRAVERE THERAPEUTICS CALL Call 7,100 162.96 0 n/a n/a n/a
2023-02-02 2022-12-31 13F TRAVERE THERAPEUTICS CALL Call 2,700 -86.36 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F TRAVERE THERAPEUTICS CALL Call 19,800 -36.33 487 -35.33 n/a n/a n/a
2022-08-03 2022-06-30 13F TRAVERE THERAPEUTICS CALL Call 31,100 1,010.71 753 945.83 n/a n/a n/a
2022-05-02 2022-03-31 13F TRAVERE THERAPEUTICS CALL Call 2,800 -9.68 72 -25.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A TRAVERE THERAPEUTICS CALL Call 3,100 -3.12 96 95.92 n/a n/a n/a
2022-02-04 2021-12-31 13F TRAVERE THERAPEUTICS CALL Call 3,200 49 n/a n/a n/a
2021-10-28 2021-09-30 13F TRAVERE THERAPEUTICS CALL Call 3,200 0.00 49 6.52 n/a n/a n/a
2021-08-12 2021-06-30 13F TRAVERE THERAPEUTICS CALL Call 3,200 1,584.21 46 -90.30 n/a n/a n/a
2021-04-26 2021-03-31 13F TRAVERE THERAPEUTICS CALL Call 190 955.56 474 867.35 n/a n/a n/a
2021-02-02 2020-12-31 13F TRAVERE THERAPEUTICS CALL Call 18 -78.31 49 -67.97 n/a n/a n/a
2020-10-14 2020-09-30 13F RETROPHIN CALL Call 83 361.11 153 212.24 n/a n/a n/a
2020-07-13 2020-06-30 13F RETROPHIN CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-29 2020-03-31 13F RETROPHIN CALL Call 454 4,944.44 662 5,416.67 n/a n/a n/a
2020-02-05 2019-12-31 13F RETROPHIN CALL Call 9 -81.63 12 -78.57 n/a n/a n/a
2019-10-15 2019-09-30 13F RETROPHIN CALL Call 49 19.51 56 -31.71 n/a n/a n/a
2019-07-26 2019-06-30 13F RETROPHIN CALL Call 41 -31.67 82 -39.26 n/a n/a n/a
2019-04-18 2019-03-31 13F RETROPHIN CALL Call 60 46.34 135 46.74 n/a n/a n/a
2019-01-16 2018-12-31 13F RETROPHIN CALL Call 41 -88.86 92 -91.30 n/a n/a n/a
2018-10-23 2018-09-30 13F RETROPHIN CALL Call 368 36,700.00 1,057 52,750.00 n/a n/a n/a
2018-07-30 2018-06-30 13F RETROPHIN CALL Call 1 -97.37 2 100.00 n/a n/a n/a
2018-04-26 2018-03-31 13F RETROPHIN CALL Call 38 -30.91 1 -66.67 n/a n/a n/a
2018-01-10 2017-12-31 13F RETROPHIN CALL Call 55 -49.07 3 -78.57 n/a n/a n/a
2017-10-25 2017-09-30 13F RETROPHIN CALL Call 108 68.75 14 100.00 n/a n/a n/a
2017-07-12 2017-06-30 13F RETROPHIN CALL Call 64 -32.63 7 -41.67 n/a n/a n/a
2017-04-21 2017-03-31 13F RETROPHIN CALL Call 95 -41.72 12 -74.47 n/a n/a n/a
2017-01-11 2016-12-31 13F RETROPHIN CALL Call 163 77.17 47 14.63 n/a n/a n/a
2016-10-07 2016-09-30 13F RETROPHIN CALL Call 92 109.09 41 241.67 n/a n/a n/a
2016-07-18 2016-06-30 13F RETROPHIN CALL Call 44 -45.68 12 200.00 n/a n/a n/a
2016-04-14 2016-03-31 13F RETROPHIN CALL Call 81 76.09 4 100.00 n/a n/a n/a
2016-01-20 2015-12-31 13F RETROPHIN CALL Call 46 -79.82 2 -88.89 n/a n/a n/a
2015-10-08 2015-09-30 13F RETROPHIN CALL Call 228 470.00 18 125.00 n/a n/a n/a
2015-07-08 2015-06-30 13F RETROPHIN CALL Call 40 -87.30 8 -94.74 n/a n/a n/a
2015-04-21 2015-03-31 13F RETROPHIN CALL Call 315 570.21 152 2,940.00 n/a n/a n/a
2015-03-04 2014-12-31 13F RETROPHIN CALL Call 47 5 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-02 2020-12-31 13F RETROPHIN PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-10-14 2020-09-30 13F RETROPHIN PUT Put 9 -93.53 16 -94.35 n/a n/a n/a
2020-07-13 2020-06-30 13F RETROPHIN PUT Put 139 -18.24 283 14.11 n/a n/a n/a
2020-04-29 2020-03-31 13F RETROPHIN PUT Put 170 2,328.57 248 2,655.56 n/a n/a n/a
2020-02-05 2019-12-31 13F RETROPHIN PUT Put 7 -97.46 9 -97.18 n/a n/a n/a
2019-10-15 2019-09-30 13F RETROPHIN PUT Put 276 688.57 319 355.71 n/a n/a n/a
2019-07-26 2019-06-30 13F RETROPHIN PUT Put 35 -63.54 70 -67.74 n/a n/a n/a
2019-04-18 2019-03-31 13F RETROPHIN PUT Put 96 -54.72 217 -54.70 n/a n/a n/a
2019-01-16 2018-12-31 13F RETROPHIN PUT Put 212 19.10 479 -6.26 n/a n/a n/a
2018-10-23 2018-09-30 13F RETROPHIN PUT Put 178 -16.04 511 6.68 n/a n/a n/a
2018-04-26 2018-03-31 13F RETROPHIN PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-01-10 2017-12-31 13F RETROPHIN PUT Put 34 0.00 0 n/a n/a n/a
2017-10-25 2017-09-30 13F RETROPHIN PUT Put 34 70.00 0 n/a n/a n/a
2017-07-12 2017-06-30 13F RETROPHIN PUT Put 20 -70.59 0 -100.00 n/a n/a n/a
2017-04-21 2017-03-31 13F RETROPHIN PUT Put 68 -80.52 8 -72.41 n/a n/a n/a
2017-01-11 2016-12-31 13F RETROPHIN PUT Put 349 267.37 29 222.22 n/a n/a n/a
2016-10-07 2016-09-30 13F RETROPHIN PUT Put 95 30.14 9 12.50 n/a n/a n/a
2016-07-18 2016-06-30 13F RETROPHIN PUT Put 73 -29.13 8 -50.00 n/a n/a n/a
2016-04-14 2016-03-31 13F RETROPHIN PUT Put 103 -44.62 16 -27.27 n/a n/a n/a
2016-01-20 2015-12-31 13F RETROPHIN PUT Put 186 80.58 22 37.50 n/a n/a n/a
2015-10-08 2015-09-30 13F RETROPHIN PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-07-08 2015-06-30 13F RETROPHIN PUT Put 11 -87.78 2 100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F RETROPHIN PUT Put 90 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.